Role of the CXCR3‑mediated TLRs/MyD88 signaling pathway in promoting the development of hepatitis B into cirrhosis and liver cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Role of the CXCR3‑mediated TLRs/MyD88 signaling pathway in promoting the development of hepatitis B into cirrhosis and liver cancer

Published:2021-08-20 Issue:4 Volume:24 Page:
ISSN:1791-2997
Container-title:Molecular Medicine Reports
language:
Short-container-title:Mol Med Rep

Author:

Yuan Gang¹,Chen Bin²,Meng Yina³,Lu Jialin³,Shi Xiaojun⁴,Hu Airong⁵,Hu Yaoren⁵,Wang Donghui¹

Affiliation:

1. Department of Acute Infection, Hwa Mei Hospital, University of Chinese Academy of Sciences, Ningbo, Zhejiang 315010, P.R. China

2. Hepatology Center, Hwa Mei Hospital, University of Chinese Academy of Sciences, Ningbo, Zhejiang 315010, P.R. China

3. Institute of Hepatology, Ningbo University School of Medicine, Ningbo, Zhejiang 315211, P.R. China

4. Department of Hepato‑Oncology, Hwa Mei Hospital, University of Chinese Academy of Sciences, Ningbo, Zhejiang 315010, P.R. China

5. Institute of Hepatology, Hwa Mei Hospital, University of Chinese Academy of Sciences, Ningbo, Zhejiang 315010, P.R. China

Publisher

Spandidos Publications

Subject

Cancer Research,Oncology,Genetics,Molecular Biology,Molecular Medicine,Biochemistry

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. MyD88's function in the emergence and growth of tumors;Clinical Cancer Bulletin;2024-09-01

2. Small HBV surface antigen drives regorafenib resistance in HCC via KIAA1429‐dependent m6A modification of CCR9;Journal of Medical Virology;2024-08-29

3. MyD88 and Its Inhibitors in Cancer: Prospects and Challenges;Biomolecules;2024-05-07

4. MiR-525-5p inhibits diffuse large B cell lymphoma progression via the Myd88/NF-κB signaling pathway;PeerJ;2023-11-06

5. Update on the role of Chemokines and Chemokine Receptors in Liver Fibrosis;Journal of Gastrointestinal and Liver Diseases;2023-06-22

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3